CLOSTRIDIUM DIFFICILE

Clinical trials for CLOSTRIDIUM DIFFICILE explained in plain language.

Never miss a new study

Get alerted when new CLOSTRIDIUM DIFFICILE trials appear

Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug aims to stop debilitating gut infection from coming back

Prevention Recruiting now

This study is testing whether a 14-day course of an investigational oral drug called VE303 can prevent a C. difficile infection from coming back after standard antibiotic treatment. It will enroll 852 people who have just been treated for a C. diff infection and are at high risk …

Matched conditions: CLOSTRIDIUM DIFFICILE

Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention

Last updated Mar 12, 2026 13:51 UTC

CLOSTRIDIUM DIFFICILE

Get alerted when new CLOSTRIDIUM DIFFICILE trials appear

New drug aims to stop debilitating gut infection from coming back